TC Biopharm (Holdings) Plc
TCBPY
$0.335
$0.026.35%
OTC PK
| 12/31/2024 | 09/30/2024 | ||||
|---|---|---|---|---|---|
| Revenue | -- | -- | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | -- | -- | |||
| Cost of Revenue | -- | -- | |||
| Gross Profit | -- | -- | |||
| SG&A Expenses | -1.59% | 91.54% | |||
| Depreciation & Amortization | -- | -- | |||
| Other Operating Expenses | -1.30% | -83.76% | |||
| Total Operating Expenses | -1.59% | 79.53% | |||
| Operating Income | 1.59% | -79.53% | |||
| Income Before Tax | 1.59% | -79.48% | |||
| Income Tax Expenses | 1.59% | -112.37% | |||
| Earnings from Continuing Operations | 1.59% | -77.74% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 1.59% | -77.74% | |||
| EBIT | 1.59% | -79.53% | |||
| EBITDA | 1.59% | -85.63% | |||
| EPS Basic | 1.59% | 74.33% | |||
| Normalized Basic EPS | 1.59% | 74.08% | |||
| EPS Diluted | 1.59% | 73.89% | |||
| Normalized Diluted EPS | 1.59% | 74.08% | |||
| Average Basic Shares Outstanding | 0.00% | 592.77% | |||
| Average Diluted Shares Outstanding | -- | -- | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||